Research on Novel Biomarkers for Early Diagnosis of Parkinson's Disease - Trial NCT06232772
Access comprehensive clinical trial information for NCT06232772 through Pure Global AI's free database. This phase not specified trial is sponsored by Yousheng Xiao and is currently Not yet recruiting. The study focuses on Parkinson's Disease. Target enrollment is 600 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
ฮฑ- Synuclein Ultrafine Fluorescence Detection Method
Observational
diagnostic test
Sponsor & Location
Yousheng Xiao
Guangxi Medical University
Timeline & Enrollment
N/A
Mar 01, 2024
Jun 01, 2026
Primary Outcome
Primary Outcome 1๏ผAccuracy and precision๏ผ,Primary Outcome 2๏ผSensitivity and specificity๏ผ
Summary
The goal of this observational study is to evaluate the detection ability of ฮฑ-Synuclein
 Ultrafine Fluorescence Detection Method for body fluids (Such as saliva, urine, cerebrospinal
 fluid, and blood, etc.) and skin in Parkinson's patients.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06232772
Non-Device Trial